Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 May;57(1):e1–e6. doi: 10.1097/QAI.0b013e3182158980

TABLE 1.

Changes in patient volume at following rapid scale-up in clinic capacity and infrastructure, 43 sites. Patient volume increased from a median of 241 pre-ART and ART patients per site at the end of the first 3 months of the President’s Emergency Plan for AIDS Relief (PEPFAR) support to a median of 1,649 pre-ART and ART patients per site by the end of the evaluation.

Number of patients at each site after the first 3 months of PEPFAR support:*
   Individuals receiving HIV care (ART+pre-ART) Median (range): 241 (0–7,888)
   Individuals receiving ART Median (range): 117 (0–6,496)
   Pediatric patients as a percentage of total ART patients Median: (range): 0.0% (0.0% –100.0%)
Number of patients at each site at the end of evaluation:
   Individuals receiving HIV care (ART+pre-ART) Median (range): 1,649 (119–9,899)
   Individuals receiving ART Median (range): 922 (17–9,315)
   Pediatric patients as a percentage of total ART patients Median: (range) 2.6% (0.0%–100.0%)
Average quarterly growth of patient volume at each site over evaluation (percentage):
   Individuals receiving care (ART+pre-ART) Median (range): 43.1% (1.3%–345.3%)
   Individuals receiving ART Median (range): 55.8% (3.6%–289.6%)
Average quarterly growth of patient volume at each site over evaluation (absolute):
   Individuals receiving care (ART+pre-ART) Median (range): 293 (26–1,261)
   Individuals receiving ART Median (range): 205 (16–776)
*

Some facilities did not enroll patients during the first 3 month of PEPFAR.